FIP was historically a fatal diagnosis, but antiviral treatments have transformed outcomes - though access and cost remain welfare barriers.
FIP causes severe, painful illness and was until recently uniformly fatal. The existence of highly effective treatment that is inaccessible to most affected cats due to cost and regulatory barriers represents a significant avoidable welfare failure. Advocating for licensed, affordable access to antivirals is a high-priority welfare intervention.